WeChat Mini Program
Old Version Features

Results from Tandem Phase 1 Studies Evaluating the Safety, Reactogenicity and Immunogenicity of the Vaccine Candidate Antigen Plasmodium Falciparum FVO Merozoite Surface Protein-1 (MSP1 42 ) Administered Intramuscularly with Adjuvant System AS01

Nekoye Otsyula,Evelina Angov,Elke Bergmann-Leitner,Margaret Koech,Farhat Khan,Jason Bennett,Lucas Otieno,James Cummings,Ben Andagalu,Donna Tosh,John Waitumbi,Nancy Richie,Meng Shi,Lori Miller,Walter Otieno, Godfrey Allan Otieno,Lisa Ware,Brent House,Olivier Godeaux,Marie-Claude Dubois,Bernhards Ogutu,W Ripley Ballou,Lorraine Soisson,Carter Diggs,Joe Cohen,Mark Polhemus,D Gray Heppner,Christian F Ockenhouse,Michele D Spring

Malaria journal（2013）

Cited 31|Views9
Key words
Malaria,Vaccine,Merozoite surface protein-1,Plasmodium
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined